✦ LIBER ✦

Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma

✍ Scribed by Panagiotis Tsirigotis; Liliane Dray; Igor B. Resnick; Aliza Ackerstein; Benjamin Gesundheit; Sharon Elad; Reuven Or; Michael-Yechiel Shapira

Publisher: Springer
Year: 2009
Tongue: English
Weight: 187 KB
Volume: 89
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-009-0808-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab long-term maintenance therapy

Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma

✍ Frank Neumann; Stefani Harmsen; Simona Martin; Ralf Kronenwett; Mustafa Kondakci 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 96 KB

Rituximab therapy increased post-transpl

Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic stem cell transplantation

✍ Ming-Yang Lee; Tzeon-Jye Chiou; Liang-Tsai Hsiao; Muh-Hwa Yang; Pang-Chan Lin; S 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 111 KB

Pretransplantation positron emission tom

Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma

✍ Enrico Derenzini; Gerardo Musuraca; Stefano Fanti; Vittorio Stefoni; Monica Tani 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Rituximab added to an intensified salvag

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

✍ Michal Sieniawski; Oliver Staak; Jan-Peter Glossmann; Thorsten Reineke; Helena S 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 178 KB

Therapeutic results in patients with rel

Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation

✍ Felicetto Ferrara; Assunta Viola; Carolina Copia; Ettore Mariano Schiavone; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,

Allogeneic stem cell transplantation in

Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation

✍ Ji-Won Kim; Byung-Su Kim; Soo-Mee Bang; Inho Kim; Dong Hwan Kim; Won Seog Kim; D 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 197 KB